Thyrocare Q2 profit slips 68% to ₹15 Cr on ₹45 Cr exceptional expense

Thyrocare's net profit for the September quarter (Q2 FY27) fell 68.2% year on year to ₹15.2 Cr from ₹47.8 Cr. The drop came from a ₹45 Cr impairment loss on its Nueclear Healthcare investment, which it has proposed to sell for around ₹141.4 Cr. Revenue from operations grew 25.1% to ₹270.8 Cr. A shareholder postal ballot seeks approval for the divestment.

Source: Inc42 ↗